AstraZeneca Drug Substance Manufacturing Facility in Virginia
Sector: Manufacturing (Industrial) • Location: Virginia, United States
Source: AInvest
A new multi-billion-dollar drug substance manufacturing facility planned in the Commonwealth of Virginia, focusing on producing drug substances for weight management and metabolic therapies. It will be AstraZeneca's largest single manufacturing investment globally and will use advanced technologies such as AI, automation, and data analytics to optimize production.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | planned |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | A new multi-billion-dollar drug substance manufacturing facility planned in the Commonwealth of Virginia, focusing on producing drug substances for weight management and metabolic therapies. It will be AstraZeneca's largest single manufacturing investment globally and will use advanced technologies such as AI, automation, and data analytics to optimize production. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |